Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to Paclitaxel

Seiji Mabuchi(The University of Osaka), Yuji Murata(The University of Osaka), Keiichi Tasaka(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Koji Hisamoto(Osaka Police Hospital), Emi Arimoto‐Ishida(The University of Osaka), Jun Hayakawa(The University of Osaka), Kazuhiro Takahashi, Kazushige Adachi, Yukihiro Nishio, Akiko Kimura(The University of Osaka), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Yuki Nakatsuji(The University of Osaka)
Journal of Biological Chemistry
August 30, 2002
10.1074/jbc.m204042200
Cited by 172

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
|Molecular Cancer Research|2016|232
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Estrogen Suppresses Transcription of Lipoprotein Lipase Gene
|Journal of Biological Chemistry|2000|209